Transforming
Lifesciences with
Artificial Intelligence

Discover how a leading global MedTech company transformed its ESG strategy using AI-powered insights from Vamstar. This case study explores how the company increased tender visibility by 500%, improved margins by 6-9%, and positioned itself as an industry leader in sustainability. Learn how AI-driven data analysis, real-time ESG tracking, and proactive engagement strategies enabled the company to overcome fragmented processes and gain a competitive edge in the rapidly evolving European market.

A leading international MedTech company aimed to improve market visibility and strategic decision-making. Vamstar implemented an AI-powered data orchestration engine, providing comprehensive analysis of tender data and market insights. This transformation enhanced the client’s understanding of market trends and enabled targeted strategies for product introduction and competitive differentiation. Key outcomes included a 4.5% improvement in margins and a 9.2% increase in revenues, demonstrating the significant impact of AI in driving growth and profitability in the MedTech sector.

Discover how a top pharmaceutical company revitalised its tendering strategy, achieving a 73% boost in efficiency, a 17% increase in win rates, and a 9% margin expansion through Vamstar’s strategic data integration and automated pricing solutions.

Overcome Global Market Challenges through Data-Driven Strategies.

A global manufacturer of medical devices and consumables needed to evaluate how emerging ESG (Environmental, Social, and Governance) requirements would impact product marketability across the EU4, UK, and Nordics. Seeking to better understand market risks and opportunities, the client approached Vamstar for insights into differentiation strategies to expand market share.

A global manufacturer of medical devices and consumables needed to evaluate how emerging ESG (Environmental, Social, and Governance) requirements would impact product marketability across the EU4, UK, and Nordics. Seeking to better understand market risks and opportunities, the client approached Vamstar for insights into differentiation strategies to expand market share.

MedTech Europe engaged Vamstar to conduct a thorough examination of ESG criteria adoption within European MedTech tenders. Leveraging advanced natural language processing and machine learning technologies, Vamstar analyzed over 15,000 tender documents. This comprehensive study provided insights into the increasing importance of ESG factors, identifying growth in ESG weightage from less than 5% in 2020 to 7.3% in 2022, and highlighting best practices that foster effective ESG integration. The analysis also delved into the specific language used in tenders to articulate ESG expectations, offering strategic guidance for enhancing sustainability in procurement processes.

Vamstar offered a strategic solution by introducing its advanced Hospital Data Orchestration methodology. Our team collaborated closely with the hospital’s leadership to streamline their ERP and EHS systems, leveraging proprietary Code Matching Algorithms and machine learning technology to clean, organise, and normalise the data, providing a consistent flow of actionable analytics. 

A leading pharmaceutical company with a robust international presence and growing operations in Europe found itself grappling with increased competition in the generics market, particularly in tenders following Loss of Exclusivity (LoE), where market prices plummeted by up to 95%.